Other reports have shown that IL-9 can promote the progression of different hematological system tumors, such as Hodgkin’s lymphoma [65], acute lymphoblastic leukemia [66] and NK T cell lymphoma [67]. The gene discussed is IL9; the disease is Hodgkins lymphoma.